The store will not work correctly when cookies are disabled.
3-Benzamido-5-chloropicolinic acid
ID: ALA4796377
PubChem CID: 162676309
Max Phase: Preclinical
Molecular Formula: C13H9ClN2O3
Molecular Weight: 276.68
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1cc(Cl)cnc1C(=O)O)c1ccccc1
Standard InChI: InChI=1S/C13H9ClN2O3/c14-9-6-10(11(13(18)19)15-7-9)16-12(17)8-4-2-1-3-5-8/h1-7H,(H,16,17)(H,18,19)
Standard InChI Key: NBDLWABWFZUEPL-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
24.6175 -15.4564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6164 -16.2760 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3244 -16.6849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0341 -16.2755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0312 -15.4528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3226 -15.0476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3242 -17.5021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6164 -17.9105 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.0318 -17.9109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.7424 -16.6830 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4495 -16.2733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1578 -16.6808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4482 -15.4561 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.1545 -17.4964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8620 -17.9038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5700 -17.4940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5661 -16.6726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8580 -16.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3202 -14.2304 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
7 8 1 0
7 9 2 0
4 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 12 1 0
6 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 276.68 | Molecular Weight (Monoisotopic): 276.0302 | AlogP: 2.69 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.29 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 0.92 | CX Basic pKa: 4.99 | CX LogP: 1.92 | CX LogD: -0.13 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.90 | Np Likeness Score: -1.47 |
References
1. Khalifa MM,Martorelli Di Genova B,McAlpine SG,Gallego-Lopez GM,Stevenson DM,Rozema SD,Monaghan NP,Morris JC,Knoll LJ,Golden JE. (2020) Dual-Stage Picolinic Acid-Derived Inhibitors of Toxoplasma gondii., 11 (12): [PMID:33335660] [10.1021/acsmedchemlett.0c00267] |